3-hydroxyflavone has been researched along with Angiogenesis, Pathologic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dianisková, K; Gál, P; Kraus, V; Mirossay, A; Mirossay, L; Mojzis, J; Pilátová, M; Sarisský, M; Stupáková, V; Varinská, L | 1 |
| Armstrong, S; Beausejour, C; Beltran, PJ; Buscarlet, M; Cagnone, G; Chaney, SY; Crespo-Garcia, S; Dasgupta, S; Dejda, A; Dogan, T; Dubrac, A; Fournier, F; Girouard, G; Guber, V; Joyal, JS; Juneau, R; Mallette, FA; Marquess, D; O'Brien, R; Patel, P; Pilon, F; Rao, SR; Ryan, RD; Sapieha, P; Tsuruda, PR; Wilson, AM; Yohn, CB | 1 |
| Choi, DY; Huh, JE; Jeon, G; Lee, JD; Park, DS; Woo, HS; Yang, HR | 1 |
| Chabot, GG; Scherman, D; Seguin, J; Touil, YS | 1 |
| Agarwal, R; Bhat, TA; Nambiar, D; Pal, A; Singh, RP | 1 |
5 other study(ies) available for 3-hydroxyflavone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Effect of selected flavones on cancer and endothelial cells.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cells, Cultured; DNA Fragmentation; Endothelial Cells; Flavones; Flavonoids; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasms; Neovascularization, Pathologic; Quercetin | 2010 |
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition.
Topics: Animals; Apoptosis; bcl-X Protein; Cellular Senescence; Collagen Type I, alpha 1 Chain; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Endothelial Cells; Female; Flavonols; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Pathologic; Retinal Diseases; Tacrolimus | 2021 |
Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cell Movement; Cell Proliferation; Collagen Type II; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fibroblasts; Flavonoids; Flavonols; Humans; Hypersensitivity, Delayed; Imidazoles; Interleukin-1beta; Mice; Mice, Inbred DBA; Neovascularization, Pathologic; Oxazolone; Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Rhus; Synovial Membrane; Vascular Endothelial Growth Factor A | 2009 |
Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Cycle; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Cyclophosphamide; Endothelial Cells; Female; Flavonoids; Flavonols; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; NIH 3T3 Cells; Tubulin Modulators; Tumor Burden | 2011 |
Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Line, Transformed; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Down-Regulation; Endothelial Cells; Flavonoids; Flavonols; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitor of Apoptosis Proteins; Male; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-bcl-2; Survivin; Vascular Endothelial Growth Factor A | 2012 |